Nguyen Mai1, Viollandi Prifti1, Kihong Lim2, Michael A O'Reilly3, Minsoo Kim2, Marc W Halterman4. 1. Neuroscience, University of Rochester School of Medicine and Dentistry, Rochester NY 14642 United States. 2. Microbiology & Immunology, University of Rochester School of Medicine and Dentistry, Rochester NY 14642 United States. 3. Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester NY 14642 United States. 4. Departments of Neurology & Neuroscience, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642 United States; Departments of Neurology, University of Rochester School of Medicine and Dentistry, Rochester NY 14642 United States. Electronic address: Marc_Halterman@urmc.rochester.edu.
Abstract
BACKGROUND AND OBJECTIVES: Studies implicate the lung in moderating systemic immune activation via effects on circulating leukocytes. In this study, we investigated whether targeted expression of the antioxidant extracellular superoxide dismutase (SOD3) within the lung would influence post-ischemic peripheral neutrophil activation and CNS reperfusion injury. METHODS: Adult, male mice expressing human SOD3 within type II pneumocytes were subjected to 15 min of transient global cerebral ischemia. Three days post-reperfusion, lung and brain tissue was collected and analyzed by immunohistochemistry for inflammation and injury markers. In vitro motility and neurotoxicity assays were conducted to ascertain the direct effects of hSOD3 on PMN activation. Results were compared against C57BL/6 age and sex-matched controls. RESULTS: Relative to wild-type controls, hSOD3 heterozygous mice exhibited a reduction in lung inflammation, blood-brain barrier damage, and post-ischemic neuronal injury within the hippocampus and cortex. PMNs harvested from hSOD3 mice were also resistant to LPS priming, slower-moving, and less toxic to primary neuronal cultures. CONCLUSIONS: Constitutive, focal expression of hSOD3 is neuroprotective in a model of global cerebral ischemia-reperfusion injury. The underlying mechanism of SOD3-dependent protection is attributable in part to effects on the activation state and toxic potential of circulating neutrophils. These results implicate lung-brain coupling as a determinant of cerebral ischemia-reperfusion injury and highlight post-stroke lung inflammation as a potential therapeutic target in acute ischemic cerebrovascular injuries.
BACKGROUND AND OBJECTIVES: Studies implicate the lung in moderating systemic immune activation via effects on circulating leukocytes. In this study, we investigated whether targeted expression of the antioxidant extracellular superoxide dismutase (SOD3) within the lung would influence post-ischemic peripheral neutrophil activation and CNS reperfusion injury. METHODS: Adult, male mice expressing humanSOD3 within type II pneumocytes were subjected to 15 min of transient global cerebral ischemia. Three days post-reperfusion, lung and brain tissue was collected and analyzed by immunohistochemistry for inflammation and injury markers. In vitro motility and neurotoxicity assays were conducted to ascertain the direct effects of hSOD3 on PMN activation. Results were compared against C57BL/6 age and sex-matched controls. RESULTS: Relative to wild-type controls, hSOD3 heterozygous mice exhibited a reduction in lung inflammation, blood-brain barrier damage, and post-ischemic neuronal injury within the hippocampus and cortex. PMNs harvested from hSOD3mice were also resistant to LPS priming, slower-moving, and less toxic to primary neuronal cultures. CONCLUSIONS: Constitutive, focal expression of hSOD3 is neuroprotective in a model of global cerebral ischemia-reperfusion injury. The underlying mechanism of SOD3-dependent protection is attributable in part to effects on the activation state and toxic potential of circulating neutrophils. These results implicate lung-brain coupling as a determinant of cerebral ischemia-reperfusion injury and highlight post-stroke lung inflammation as a potential therapeutic target in acute ischemic cerebrovascular injuries.
Authors: Zachary Van Rheen; Cheryl Fattman; Shannon Domarski; Susan Majka; Dwight Klemm; Kurt R Stenmark; Eva Nozik-Grayck Journal: Am J Respir Cell Mol Biol Date: 2010-06-10 Impact factor: 6.914
Authors: Shreyas K Roy; Brian D Kubiak; Scott P Albert; Christopher J Vieau; Louis Gatto; Lorne Golub; Hsi-Ming Lee; Suraj Sookhu; Yoram Vodovotz; Gary F Nieman Journal: Shock Date: 2012-04 Impact factor: 3.454
Authors: Michael Krams; Kennedy R Lees; Werner Hacke; Andrew P Grieve; Jean-Marc Orgogozo; Gary A Ford Journal: Stroke Date: 2003-10-16 Impact factor: 7.914